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Viewpoint
toplasmic sperm injection (ICSI) is directly associ
transfer of multiple embryos, single embryo transfer
ICSI cycles has been strongly promoted as the most e
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pregnancy. O e recent randomised trial has shown
SET and, if needed, subsequently transferring one f180 MJA • Volume 184 NumbABSTRACT
• Multiple pregnancy, with its adverse outcomes, is a significant 
problem in assisted reproductive technology.
• Single embryo transfer (SET) is the only feasible solution for 
reducing the rate of multiple pregnancy.
• Many patients and some clinicians remain to be convinced 
that SET is a better clinical option.
• Adequate education, based on available evidence, is one 
MJA 2006; 184: 180–181
important way to promote the use of SET.ne
og
naO  of the major problems of assisted reproductive technol-y (ART) treatment is the high rate of multiple preg-ncy. Based on the latest published Australian data in
2002, 18.3% of ART deliveries were twins and 0.6% were triplets.1
The risk of adverse outcomes is much higher for both pregnant
women and children born from multiple pregnancy. As the chance
of multiple pregnancy from in-vitro fertilisation (IVF) and intracy-
ated with the





embryo, can achieve a similar pregnancy rate and live birth rate as
double embryo transfer.2
In Australia, there are voluntary clinical guidelines to promote
the use of SET in several IVF clinics. Some countries have
mandatory legislation. For example, in Belgium, the introduction of
a new law increased SET from 14% to 49% of IVF/ICSI cycles,
providing a significant decrease in the twin pregnancy rate without
affecting the overall pregnancy rate.3 In Australia, the accreditation
system operated by the Fertility Society of Australia (Reproductive
Technology Accreditation Committee, RTAC) requests clinics gen-
erally transfer no more than two embryos in one treatment cycle.
Many clinicians would transfer two embryos per cycle, although
SET has been proposed as the better clinical option.4 Despite
increased attention to the risk of multiple births in patient informa-
tion and counselling practice, many Australian IVF clinics and a
large proportion of patients continue to choose double embryo
transfer. In 2002, less than 30% of Australian women undergoing
IVF received a single embryo transfer per IVF cycle.1 Although this
proportion will almost certainly have increased in the past few
years, the implantation rates (the chance of an embryo implanting
in utero and initiating a pregnancy) have improved greatly in many
IVF clinics following the introduction of new culture techniques,
and this leads to a high likelihood of twin implantation with double
embryo transfer. The prevalence of twin pregnancy will be signifi-
cantly reduced only when the use of SET is also substantially
increased. Box 1 indicates that pregnancy rates have improved
while fewer embryos per cycle have been transferred.
Information on the chance of pregnancy and risk of possible
adverse outcomes, in a form that is easily understandable, is
essential for patients’ treatment decision-making process. The
choice is often dependent upon their understanding and accept-
ance of the information.5 Clinicians usually respect patient prefer-
ence for treatment options, especially within the guidelines. The
multicentre Australian study of SET had to be stopped because of
the difficulty in recruiting patients, largely caused by their reluc-
tance to be randomised once adequate information had been
provided. At the same time, clinicians have great influence on
patients’ choice depending on how they interpret the existing
evidence. There may be a tension in the consideration between the
safety and long-term benefits to children and the desire for
achieving a pregnancy in a treatment cycle. Patients often accept or
even desire twins, possibly because of the desire for pregnancy and
reduction of the cost and inconvenience of IVF, and only realise the
extra burden of twins on their life later.6 Some may even like to
reach the objective of a complete family in one treatment cycle
through the birth of twins.
1 Trends in pregnancy rates and number of 
embryos transferred*
* Mean number of embryos transferred per cycle, and pregnancy and multiple 
pregnancy rates (%) at an Adelaide IVF clinic (Repromed). ◆
10%
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VIEWPOINTFor many, there can be a genuine lack of appreciation of the risk
of multiple pregnancy and its consequences. It is not enough just
to inform patients about the chance of twin or multiple pregnancy
— it may be necessary to provide information to patients about the
increased risk of serious complications, like cerebral palsy. It is
unclear whether information can change patients’ choice, as one
study failed to show that additional information had increased
patients’ acceptance of elective SET.7 Our own experience in
recruiting patients for a SET trial indicated that provision of
detailed information on the risk of twins and associated adverse
outcomes may have contributed to the increase of 17% SET in
2001 to nearly 50% SET in 2004 in our patient population.
Education of clinicians is equally important, as patients are
strongly influenced by both the official policy of the clinic and the
clinicians’ advice. Medical personnel have a good knowledge of
increased risk of adverse outcomes of twins (Box 2). Although
outcomes are similar for twins conceived by ART and naturally
conceived twins,8 it is clear that twins conceived by ART have
much poorer outcomes than singletons conceived either naturally
or by ART. One study of more than 700 ART twin pregnancies in
Australia showed that the perinatal mortality rate for the twins was
much higher than for singletons conceived by ART (44.8 v 11.7
per 1000 births).9 Some recent publications have highlighted
particular risks in twins conceived by ART, such as high discordant
birth weight and increased admissions to neonatal intensive care
units.10 Growing evidence suggests that the high rate of in-utero
death in a twin pregnancy or vanishing twins (around 25%)9 as a
result of double embryo transfer may be a cause of adverse
outcome in singletons conceived by IVF.11 More important for
infertility clinics and many clinicians is the gradual accumulation
of quality evidence that elective SET can achieve the same
pregnancy rate as double embryo transfer in patients who have
good prognosis. Therefore, promoting SET does not jeopardise
patients’ chance of achieving pregnancy. Elective SET is substan-
tially cheaper in health economic terms than double embryo
transfer in women younger than 38 years in their first IVF/ICSI
cycle when maternal, neonatal and total costs are considered.12
For both patients and clinicians, the chance of achieving a
pregnancy is a major determining factor when considering the
number of embryos to be transferred. Pregnancy rate per cycle is
an important indicator of treatment efficacy, and most patients can
comprehend it clearly. However, with the relatively generous
Medicare cover in Australia for multiple cycles of ART, many
couples undergo more than one treatment cycle, including frozen
embryo transfers, leading to the observation that the overall
chance of achieving a successful pregnancy over the course of
treatment is more relevant. A positive long-term view based on
cumulative pregnancy rates may encourage patients to accept SET.
Communicating evidence for effective patient participation in
decision-making is a key issue in the patient–physician relation-
ship and the practice of evidence-based medicine.13 There should
be a full appreciation of the risk of twins and promotion of SET as
the solution by clinicians. To improve the education of both
patients and clinicians, further research is needed to study the
process of patient decision-making to evaluate the influence of
various types of medical information, including the content and
style of medical advice, on this process.
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2 Risk of some major pregnancy and obstetric outcomes 
for twins conceived by assisted reproduction 
technologies compared with singletons, based 
on 2002 Australia data1
Singleton Twin
Birth weight (g) 3279 2379
Low and very low birth weight 8.2% 48.4%
Gestation (weeks) 38.4 35.0
Caesarean section 42.4% 71.1%
Perinatal mortality (per 1000 births) 10.9 29.3MJA • Volume 184 Number 4 • 20 February 2006 181
